The Antibody Engine With Abpro's Chan Brothers
Business Of Biotech
00:00
Immuno Oncology Vaccines
It seems like in public, an era of public-private partnership and federal funding, I mean, we saw record levels of federal funding for companies like Abpro. Speed is now highly valued and rewarded, monetarily rewarded. When you guys are getting back to that oncology point, so the work that you've done in infectious disease like COVID, how is that informing the development of your antibody candidates? You've got like, what, six or eight, immuno oncology candidates,. Yeah, I think the official number, yeah, we have a number of them. It's been super informative, had a few signs at an accelerated pace.
Transcript
Play full episode
